Vanguard Capital Wealth Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,180
| Closed | -$32K | – | 133 |
|
|
2022
Q4 | $32K | Sell |
10,180
-3,800
| -27% | -$11.9K | 0.04% | 118 |
|
|
2022
Q3 | $69K | Sell |
13,980
-3,800
| -21% | -$18.8K | 0.08% | 105 |
|
|
2022
Q2 | $73K | Sell |
17,780
-15,600
| -47% | -$64K | 0.08% | 119 |
|
|
2022
Q1 | $193K | Hold |
33,380
| – | – | 0.14% | 132 |
|
|
2021
Q4 | $250K | Sell |
33,380
-1,200
| -3% | -$8.99K | 0.18% | 109 |
|
|
2021
Q3 | $312 | Sell |
34,580
-300
| -0.9% | -$3 | 0.21% | 96 |
|
|
2021
Q2 | $417K | Buy |
34,880
+300
| +0.9% | +$3.59K | 0.32% | 85 |
|
|
2021
Q1 | $389K | Sell |
34,580
-100
| -0.3% | -$1.12K | 0.33% | 77 |
|
|
2020
Q4 | $584K | Buy |
+34,680
| New | +$584K | 0.54% | 47 |
|
|
2020
Q2 | $300K | Buy |
+33,580
| New | +$300K | 0.35% | 75 |
|
|
2019
Q4 | $261K | Buy |
31,280
+2,300
| +8% | +$19.2K | 0.27% | 102 |
|
|
2019
Q3 | $262K | Buy |
28,980
+3,900
| +16% | +$35.3K | 0.31% | 93 |
|
|
2019
Q2 | $270K | Buy |
25,080
+2,000
| +9% | +$21.5K | 0.33% | 85 |
|
|
2019
Q1 | $220K | Buy |
23,080
+1,930
| +9% | +$18.4K | 0.28% | 100 |
|
|
2018
Q4 | $242K | Buy |
21,150
+2,100
| +11% | +$24K | 0.36% | 82 |
|
|
2018
Q3 | $322K | Buy |
+19,050
| New | +$322K | 0.37% | 76 |
|